Two Sigma Advisers LP decreased its position in HCP, Inc. (NYSE:HCP) by 85.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 102,444 shares of the real estate investment trust’s stock after selling 608,382 shares during the quarter. Two Sigma Advisers LP’s holdings in HCP were worth $2,672,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in HCP. Vestpro Financial Partners Inc. dba CPF Texas bought a new stake in HCP in the 4th quarter worth approximately $103,000. Fieldpoint Private Securities LLC bought a new stake in HCP in the 3rd quarter worth approximately $147,000. Ellington Management Group LLC bought a new stake in HCP in the 4th quarter worth approximately $232,000. Smith Shellnut Wilson LLC ADV bought a new stake in HCP in the 3rd quarter worth approximately $234,000. Finally, Cullen Frost Bankers Inc. bought a new stake in HCP in the 4th quarter worth approximately $244,000. 88.49% of the stock is currently owned by institutional investors and hedge funds.
Shares of HCP stock opened at $23.16 on Friday. The firm has a market capitalization of $10,970.89, a price-to-earnings ratio of 11.98, a price-to-earnings-growth ratio of 4.31 and a beta of 0.26. The company has a debt-to-equity ratio of 1.23, a quick ratio of 0.31 and a current ratio of 0.31. HCP, Inc. has a 52 week low of $21.48 and a 52 week high of $33.67.
A number of analysts have issued reports on the company. Bank of America raised HCP from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $22.63 to $25.00 in a research note on Thursday, March 8th. Jefferies Group reaffirmed a “hold” rating and issued a $26.00 price objective on shares of HCP in a research note on Tuesday, February 13th. Zacks Investment Research downgraded HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. BMO Capital Markets set a $25.00 target price on HCP and gave the company a “hold” rating in a research report on Tuesday, February 13th. Finally, Robert W. Baird set a $24.00 target price on HCP and gave the company a “hold” rating in a research report on Thursday, February 15th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company’s stock. HCP currently has a consensus rating of “Hold” and an average target price of $27.50.
In other news, insider Kendall K. Young bought 14,000 shares of the stock in a transaction on Wednesday, February 14th. The stock was acquired at an average cost of $21.91 per share, for a total transaction of $306,740.00. Following the acquisition, the insider now owns 48,544 shares of the company’s stock, valued at $1,063,599.04. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.14% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Two Sigma Advisers LP Trims Holdings in HCP, Inc. (HCP)” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3334351/two-sigma-advisers-lp-trims-holdings-in-hcp-inc-hcp.html.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.